Natco Pharma Ltd. — Call Transcript 2020

Feb 10, 2020

==> picture [112 x 53] intentionally omitted <==

==> picture [130 x 36] intentionally omitted <==

Axis House, C-2, Wadia International Centre, P.B Marg. Worli, Mumbai 400 025 (India)

==> picture [107 x 45] intentionally omitted <==

Natco Pharma

Q3FY20 Earnings Call on 13[th] February, 2020 hosted by Axis Capital Limited

We are pleased to host, on behalf of Natco Pharma, a conference call for analysts and investors on Thursday, 13[th] February 2020 following the announcement of financial results for the third quarter ended December 2019.

The call will be initiated with a brief management discussion on the Q3FY20 earnings performance followed by an interactive Question & Answer session. The management will be represented by

• Mr. Rajeev Nannapaneni : Vice Chairman and Chief Executive Officer

• Mr. Rajesh Chebiyam : Vice President – Acquisitions, Institutional Investor Management and Corporate Communications

Details of the conference call are:

Details of the conference call are:	Details of the conference call are:
Date:Thursday, 13thFebruary 2020
Time:12:00 Noon IST	2:30 PM HK/SG
	:12:00 Noon IST
Call Lea	der:Mr. Prakash Agarwal, Axis Capital

Country	Dial in numbers
Primary	number+91 22 6280 1145 / + 91 22 7115 8046
India Lo	cal+91 7045671221(Available all over India)
International Dial In- Hong Kong800 964 448- Singapore800 101 2045- U K0 808 101 1573- USA1 866 746 2133

For further information please contact:

Prakash Agarwal

Dy Head - Research Institutional Equity Research Axis Capital Limited Direct: +91 22 4325 1145 Board: +91 22 4325 2525 Mobile: +91 9820534334 Email: prakash.agarwal@axiscap.in